# Effect of Intranasal Anti-IgE Antibodies on IgE Production

> **NCT03019237** · NA · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 15 (actual)

## Conditions studied

- Allergy

## Interventions

- **DRUG:** anti-IgE
- **OTHER:** intranasal allergen
- **OTHER:** intranasal saline

## Key facts

- **NCT ID:** NCT03019237
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03019237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03019237, "Effect of Intranasal Anti-IgE Antibodies on IgE Production". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03019237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*